paclitaxel has been researched along with Eye Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawara, H; Kawashima, Y; Maruyama, M; Noguchi, Y; Shimizu, Y; Tokuyama, Y; Uchiyama, K | 1 |
| de Vries, EG; Hofstra, LS; Willemse, PH | 1 |
| Constable, IJ; Martin, CE; Thompson, DE; van Bockxmeer, FM | 1 |
| Constable, I | 1 |
4 other study(ies) available for paclitaxel and Eye Disorders
| Article | Year |
|---|---|
Risk Factors for Eye Disorders Caused by Paclitaxel: A Retrospective Study.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Alkaline Phosphatase; Antineoplastic Agents, Phytogenic; Eye Diseases; Female; Hospitals; Humans; Logistic Models; Macular Edema; Male; Middle Aged; Nanoparticles; Neoplasms; Odds Ratio; Paclitaxel; Retrospective Studies; Risk Factors; Vision Disorders | 2018 |
Ophthalmic toxicity following paclitaxel infusion.
Topics: Antineoplastic Agents, Phytogenic; Eye Diseases; Female; Humans; Infusions, Parenteral; Middle Aged; Paclitaxel | 1997 |
Taxol for the treatment of proliferative vitreoretinopathy.
Topics: Alkaloids; Animals; Cell Membrane; Eye Diseases; Paclitaxel; Rabbits; Retinal Degeneration; Vitreous Body | 1985 |
Biological and therapeutic aspects of proliferative vitreoretinopathy.
Topics: Alkaloids; Animals; Cell Division; Choroid; Collagen; Eye Diseases; Fibroblasts; Gels; Humans; Paclitaxel; Retinal Diseases; Silicone Oils; Trifluoperazine; Vitreous Body | 1987 |